Financials

  • Market Capitalization 451.02 M
  • Employee 116
  • Founded 2013
  • CEO Shankar Musunuri
  • Website www.ocugen.com
  • Headquarter Delaware, United States
  • FIGI BBG00194VJB1
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-5.88
市销率
106.63

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2966
CCCC
C4 Therapeutics, Inc. - Common Stock
3.71 USD-3.64%-9.73%+6.30%+44.36%456.42 M USD
2975
RZLT
Rezolute, Inc. - Common Stock
4.69 USD+1.52%-5.06%+3.30%-34.13%451.61 M USD
2980
AGMB
AgomAb Therapeutics NV - ADRs representing one
13.17 USD0.00%-1.72%+4.28%-10.41%449.98 M USD
2984
PRLD
Prelude Therapeutics Incorporated - Common Stock
5.60 USD+2.38%-14.76%+20.43%+366.67%446.90 M USD

新闻